SPPI — Spectrum Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $211.40m
- $184.11m
- $10.11m
Brief: Spectrum Pharmaceuticals - On June 7, Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Spectrum Pharmaceuticals To Present Data At 2022 Asco Highlighting The Potential Predictive Capabilities Of Ctdna As A Biomarker For Poziotinib Treatment Response
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Spectrum Pharmaceuticals Reports Q1 2022 Results
Brief: Spectrum Pharmaceuticals Appoints Nora E. Brennan As Chief Financial Officer
Spectrum Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Spectrum Pharmaceuticals Appoints Brittany K. Bradrick To Board Of Directors
U.S. STOCKS ON THE MOVE-Curis, Sonos, Accolade, Shopify, Hoth Therapeutics
U.S. STOCKS ON THE MOVE-Curis Inc, Nvidia Corp, Veru Inc
Spectrum Pharma up as FDA to review its neutropenia drug candidate again
Brief: Spectrum Pharmaceuticals Announces FDA Acceptance Of BLA Resubmission For Eflapegrastim
Spectrum Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Spectrum Pharma Reports Q4 2021 And FY 2021 Financial Results
Spectrum Pharmaceuticals Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Spectrum Pharmaceuticals Presents Positive Data For Poziotinib In First-Line NSCLC Patients
Brief: Spectrum Pharmaceuticals Says Co Announced CFO, Kurt Gustafson, Has Provided Notice Of His Resignation To Pursue Other Professional Opportunities
Constellation Energy to replace Gap in S&P 500 after Exelon spin-off
Brief: S&P Dow Jones Indices Says Constellation Energy Corp. Will Replace The Gap Inc. In The S&P 500
Cell, gene therapy companies pressured by supply and manufacturing issues -BTIG